Definium Therapeutics, Inc. (DFTX) | Jive Data

Loading…

Definium Therapeutics, Inc. (DFTX) | Jive Data

Google Sheets add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

Definium Therapeutics, Inc.

DFTX · CIK 1813814

4 · Sep 18, 2026 · Director Krebs Andreas exercised options for 3,258 shares

4

Director Krebs Andreas exercised options for 3,258 shares

Filed: Sep 18, 2026
Period: Sep 18, 2026
Accession: 0001193125-26-395893
Filer: Definium Therapeutics, Inc. (0001813814) (Issuer)

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov